Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 100/100

Failure Rate

50.0%

2 terminated/withdrawn out of 4 trials

Success Rate

0.0%

-86.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

N/A
3(75.0%)
Phase 2
1(25.0%)
4Total
N/A(3)
Phase 2(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT03415828Not ApplicableRecruiting

Ethanol Gel Versus Steroid in Refractory Lumbar Discogenic Pain

Role: lead

NCT05969392Phase 2Not Yet Recruiting

Evaluation of Efficacy and Safety of Intradiscal Gelified Ethanol in Refractory Cervical Discogenic Pain

Role: lead

NCT02313350Not ApplicableWithdrawn

Intradiscal Discogel® in Resistant Sciatica

Role: collaborator

NCT02089139Not ApplicableTerminated

Treatment of Discogenic Back Pain

Role: collaborator

All 4 trials loaded